Edition:
India

Accenture PLC (ACN.N)

ACN.N on New York Stock Exchange

112.08USD
1:32am IST
Change (% chg)

$-1.63 (-1.43%)
Prev Close
$113.71
Open
$113.93
Day's High
$113.93
Day's Low
$111.93
Volume
806,538
Avg. Vol
706,484
52-wk High
$120.77
52-wk Low
$88.43

ACN.N

Chart for ACN.N

About

Accenture plc is engaged in providing management consulting, technology and outsourcing services. The Company’s business is structured around five operating groups, which together consists of 19 industry groups serving clients in industries globally. The Company’s segment includes Communications, Media & Technology, Financial... (more)

Overall

Beta: 1.18
Market Cap(Mil.): $73,988.00
Shares Outstanding(Mil.): 650.67
Dividend: 1.10
Yield (%): 1.93

Financials

  ACN.N Industry Sector
P/E (TTM): 19.20 25.02 26.35
EPS (TTM): 5.92 -- --
ROI: 41.49 8.97 6.59
ROE: 57.99 11.77 10.09

BRIEF-Accenture acquires Tecnilógica to scale its digital skills in spain

* Accenture acquires Tecnilógica to scale its open source digital skills in Spain

28 Jul 2016

BRIEF-Accenture buys end-to-end digital services company MOBGEN

* Accenture acquires MOBGEN expanding end-to-end digital services

19 Jul 2016

BRIEF-Accenture appoints Nancy Mckinstry to board of directors

* With new appointment, accenture's board now comprises 13 directors, 12 of whom are external and independent Source text for Eikon: Further company coverage: )

14 Jul 2016

BRIEF-Accenture to invest 500,000 Euros in Robovalley to create new innovations in robotics

* Accenture to invest EUR500,000 in robovalley to create new innovations in robotics

11 Jul 2016

Accenture CEO diagnosed with colon cancer, recovering from surgery

Consulting and outsourcing company Accenture Plc said Chief Executive Pierre Nanterme was diagnosed with colon cancer and is currently recovering from a surgery.

07 Jul 2016

BRIEF-Accenture CEO says was recently diagnosed with colon cancer

July 6 Accenture CEO Pierre Nanterme in letter to employees:

07 Jul 2016

Accenture CEO diagnosed with colon cancer, recovering from surgery

Consulting and outsourcing company Accenture Plc said Chief Executive Pierre Nanterme was diagnosed with colon cancer and is currently recovering from a surgery.

07 Jul 2016

Accenture CEO diagnosed with colon cancer, recovering from surgery

July 6 Consulting and outsourcing company Accenture Plc said Chief Executive Pierre Nanterme was diagnosed with colon cancer and is currently recovering from a surgery.

07 Jul 2016

Accenture revenue beats on strong demand for digital services

Accenture Plc posted better-than-expected quarterly net revenue, driven by demand for its digital services like cloud and security, particularly in its consulting unit.

23 Jun 2016

Accenture revenue beats on strong demand for digital services

Accenture Plc posted better-than-expected quarterly net revenue, driven by demand for its digital services like cloud and security, particularly in its consulting unit.

23 Jun 2016

Earnings vs. Estimates